|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 2 of 41 found articles
| Title: |
A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753) |
| Author: |
Waqar, Saiama N. Redman, Mary W. Arnold, Susanne M. Hirsch, Fred R. Mack, Philip C. Schwartz, Lawrence H. Gandara, David R. Stinchcombe, Thomas E. Leighl, Natasha B. Ramalingam, Suresh S. Tanna, Saloni H. Raddin, Ryan S. Minichiello, Katherine Bradley, Jeffrey D. Kelly, Karen Herbst, Roy S. Papadimitrakopoulou, Vassiliki A. |
| Appeared in: |
Clinical lung cancer |
| Paging: | Volume 22 () nr. 3 pages 170-177 |
| Year: |
2021 |
| Contents: | |
| Publisher: |
Elsevier Inc. |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 2 of 41 found articles
| << previous | next >> |